Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or β-blockade in patients with essential hypertension

Hypertension

Volumn 44, Issue 4, 2004, Pages 465-470

  Buus, Niels H ^a,d   Bøttcher, Morten ^a   Jørgensen, Claus G ^b   Christensen, Kent L ^a   Thygesen, Kristian ^a   Nielsen, Torsten T ^a   Mulvany, Michael J ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d Centre for Clinical Pharmacology   (Denmark)

Author keywords

Antihypertensive therapy; Arteries; Hypertension, essential; Myocardial; Vascular resistance

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; PERINDOPRIL;

ADULT; ARTERY MEDIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE PERFUSION; HEART OUTPUT; HUMAN; HYPEREMIA; IN VITRO STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL; VASCULAR RESISTANCE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; FEMALE; HEART; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERINDOPRIL; POSITRON-EMISSION TOMOGRAPHY; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 4644297102     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000141273.72768.b7     Document Type: Article

References (31)

1. Laine H, Raitakari OT, Niinikoski H, Pitkanen OP, Iida H, Viikari J, Nuutila P, Knuuti J. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol. 1998;32:147-153.
2. Parodi O, Neglia D, Palombo C, Sambuceti G, Giorgetti A, Marabotti C, Gallopin M, Simonetti I, L'Abbate A. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. Circulation. 1997;96:864-873.
3. Palombo C, Kozakova M, Magagna A, Bigalli G, Morizzo C, Ghiadoni L, Virdis A, Emdin M, Taddei S, L'Abbate A, Salvetti A. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens. 2000;18:453-459.
4. Akinboboye OO, Chou RL, Bergmann SR. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. J Am Coll Cardiol. 2002;40: 703-709.
5. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88: 993-1003.
6. Kozakova M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension. 1997;29:551-559.
7. Schafer S, Keim M, Mingers S, Strauer BE. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens. 2002;20:1431-1437.
8. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Bettoni G, Salvetti M, Muiesan P, Giulini SM. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens. 1995;13:341-347.
9. Pedrinelli R, Dell'Omo G, Gimelli A, Di Bello V, Talarico L, Corchia A, Sambuceti G, Neglia D, Parodi O. Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients. J Hypertens. 1997;15:667-673.
10. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61: 181-186.
11. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995;25; 474-481.
12. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, La Canna G, Nardi M, Guelfi D, Salvetti M, Morizzo C, Vittone F, Rosei EA. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens. 2003;21: 625-631.
13. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens. 2001;19:1001-1006.
14. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a convening enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994;23:83-91.
15. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197-204.
16. Schiffrin EL, Park JB, Pu Q. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens. 2002;20:71-78.
17. Motz W, Vogt M, Scheler S, Schwartzkopff B, Strauer BE. Improvement of coronary reserve following regression of hypertrophy resulting from blood pressure lowering therapy with a beta-receptor blocker. Dtsch Med Wochenschr. 1993;118:535-540.
18. Vogt M, Motz W, Strauer BE. Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina. Arzneimittelforschung. 1994;44: 1321-1328.
19. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension. 1996;27:1031-1038.
20. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension. 2000;36:220-225.
21. Kuhle WG, Porenta G, Huang SC, Buxton D, Gambhir SS, Hansen H, Phelps ME, Schelbert HR. Quantification of regional myocardial blood flow using 13N- ammonia and reoriented dynamic positron emission tomographic imaging. Circulation. 1992;86:1004-1017.
22. Buus NH, Boøttcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ. Influence of nitric oxide syntnase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation. 2001;104:2305-2310.
23. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618.
24. Marceau M, Kouame N, Lacourciere Y, Cleroux J. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive subjects with left ventricular hypertrophy. J Hypertens. 1998;16:673-679.
25. Hansson L. Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes. Am J Cardiol. 1986;57:29C-32C.
26. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 1993;88:62-69.
27. Bøttcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med. 1997;38:442-446.
28. Hesse B, Meyer C, Nielsen FS, Sato A, Hove JD, Holm S, Bang LE, Kofoed KF, Svendsen TL, Parving HH, Opie LH. Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition. Eur J Nucl Med Mol Imaging. 2004;31:362-368.
29. Radvan J, Marwick TH, Williams MJ, Camici PG. Evaluation of the extent and timing of the coronary hyperemic response to dipyridamole: a study with transesophageal echocardiography and positron emission tomography with oxygen 15 water. J Am Soc Echocardiogr. 1995;8: 864-873.
30. Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert HR. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood How. J Nucl Med. 1995;36:575-580.
31. Tune JD, Richmond KN, Gorman MW, Feigl EO. Control of coronary blood flow during exercise. Exp Biol Med. 2002;227:238-250.